Zonisamide
Zonisamide (AD 810) is a sulfonamide anticonvulsant used adjunctively for partial-onset seizures. Its primary mechanisms involve blocking voltage-gated sodium channels and T-type calcium currents, with additional allosteric modulation of GABA receptors. This research chemical is applied in neuroscience studies, including in vitro electrophysiology and in vivo seizure models, to investigate antiepileptic pathways.
Product Specifications
CAS Number
68291-97-4
Product Name Alternative
Sodium Channel, SodiumChannel, SH-SY5Y, seizure, Zonisamide, CI 912, CI912, CI-912, AD810, AD-810, AD 810, Apoptosis, Calcium Channel, cardiac fibroblasts, cardiac hypertrophy, CarbonicAnhydrase, Carbonic Anhydrase, Carbonic anhydrase, Carbonate dehydratase, CalciumChannel, inhibit, NRCMs, parkinson's disease, Inhibitor, epilepsy
Field of Research
Cell Biology, Metabolism Research, Pharmacology & Drug Discovery
Purity
99.05% (May vary between batches)
Solubility
DMSO:250 mg/mL (1177.97 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (9.42 mM)
Smiles
C (S (N) (=O) =O) C=1C=2C (ON1) =CC=CC2
Molecular Formula
C8H8N2O3S
Molecular Weight
212.23
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E45H13769-2 20 µg
Protein kinase like protein SgK493 (PKDCC) (NM_138370) Human Over-expression Lysate
Sign In for Pricing
View Details 
MBS1369159 Inquire
Recombinant Human BRCA1-associated ATM activator 1 (BRAT1) , partial
Sign In for Pricing
View Details